Fairvalue-Calculator Fairvalue-Calculator
EN DE

Airway Medix S.A (AWM) Fair Value & Analysis

Healthcare · PL · Market cap 31.4M PLN

Price0.2540 PLN
Fair Value0.6200 PLN
Upside+144.1%
Quality95/100
Evidence: Medium Range 0.3700 PLN – 0.8100 PLN

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Airway Medix S.A (AWM) currently trades at 0.2540 PLN, while our model-based Fair Value estimate is 0.6200 PLN — implying the stock looks roughly 144.1% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

Airway Medix S.A. engages in the research, development, and commercialization of medical devices for the mechanically ventilated patients in the intensive care units and for the patients in life-threatening conditions in the anaesthesiology departments in Poland and internationally. It offers Closed Suction System, a dual operation of balloon swiping and suction; B-Oral Care for intubated hospital patients; Hyper Form, a ventilation laryngeal masks and tube cuffs; and Cuff Pressure Regulator, single-patient use device that provides continuous regulation of pressure in inflatable ventilation tube cuffs. Airway Medix S.A. was founded in 2010 and is based in Warsaw, Poland.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Airway Medix S.A (AWM) undervalued?
As of Jun 25, 2026, our model estimates a fair value of 0.6200 PLN versus a price of 0.2540 PLN — about +144% (undervalued). Model-based estimate, not financial advice.
What is the fair value of AWM?
Our 21-model fair value for Airway Medix S.A is 0.6200 PLN (as of Jun 25, 2026), built from audited fundamentals. The current price is 0.2540 PLN.
What is the quality score of AWM?
Airway Medix S.A has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.